Shipments of ammonium perchlorate are expected to reach Iran in coming months and could fuel hundreds of ballistic missiles, the people said. Some of the material would likely be sent to militias in ...

Stock futures rose on Friday, with investors betting that the feud between Trump and his onetime ally Elon Musk would de-escalate and as markets await key jobs data. At the same time, Trump said a ...

HSBC upgraded Dr. Reddy’s Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from ...

Fintel reports that on June 5, 2025, HSBC upgraded their outlook for Dr. Reddy's Laboratories Limited - Depositary Receipt () ...

Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

HSBC upgraded Dr Reddy’s Laboratories to Buy from Hold and raised its target price to INR 1445, citing expectations that sales of semaglutide, a generic version of Novo Nordisk’s blockbuster ...

Dr. Reddy’s Laboratories shares rose 4% to Rs 1303.45 against previous close of Rs 1252.15 on BSE. Market cap of the firm ...

Dr Reddy's Lab shares jumped 4% on June 5, making it the top gainer on the Nifty 50. This surge followed the announcement of ...

Shares of Dr. Reddy’s Laboratories jumped 4 per cent to Rs 1,303, positioning it among the leading gainers on the Nifty 50.

Dr Reddy's announced a strategic partnership with Alvotech to develop a biosimilar to Keytruda, a top-selling cancer therapy ...

Dr. Reddy's had announced that it has signed a collaboration agreement with Alvotech to co-develop the biosimilar candidate ...

HSBC upgraded Brazilian planemaker Embraer to “Buy” from “Hold,” saying a record order backlog, improving output, and growing momentum in executive jets and defense deliveries support a positive ...